Eli Lilly to acquire Morphic in $3.2B deal

Mon, Jul 8, 2024, 9:56 AM

In this article:

Pharmaceutical giant Eli Lilly (LLY) has reached an agreement to purchase biopharmaceutical company Morphic (MORF) in a deal valued at $3.2 billion. This strategic move marks a notable expansion in Eli Lilly's portfolio and research capabilities.

Yahoo Finance health reporter Anjalee Khemlani explores the benefits of this deal for both companies and the broader pharmaceutical industry.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This article was written by Angel Smith

Heard on the Street: CrowdStrike May Get More Than a Slap
For CrowdStrike, the timing could hardly be worse. CrowdStrike Chief Executive George Kurtz said the issue has been “identified, isolated and a fix has been deployed” and added that it was not caused by a “security incident” or cyberattack. CrowdStrike is one of the most favored stocks in cybersecurity, with buy ratings from 88% of analysts compared to 69% for Palo Alto Networks—the largest pure-play cyber company by annual revenue.
The Wall Street Journal•
Blame One Stock For Most Of Magnificent 7's $1.3 Trillion Loss
Magnificent Seven stocks dumped more than $1.2 trillion in market value in a week. And you can mostly blame one S&P 500 stock.
Investor's Business Daily•
‘Greatest Bubble’ Nearing Its Peak, Says Black Swan Manager
Universa’s Mark Spitznagel, who has made billions from past crashes, sees a last hurrah for stocks before a severe reckoning.
The Wall Street Journal•
75% of Warren Buffett's $416 Billion Portfolio Is Invested in 5 Unstoppable Stocks
Although Buffett oversees a 44-stock, $416 billion portfolio at Berkshire Hathaway, three-quarters of invested assets have been put to work in five brand-name, time-tested businesses.
Motley Fool•
Investors can expect a huge reveal on Nvidia's upcoming earnings call that could silence AI critics, Goldman Sachs says
"We reiterate our Buy rating on NVDA as the meeting reinforced our belief in the sustainability of the ongoing Gen AI spending cycle," Goldman said.
Business Insider•
This Billionaire Founder Sold Over $13 Billion of His Company's Stock This Year Alone. Should Investors Be Worried?
Large stock sales aren't always what they seem.
Motley Fool•
Investors should 'run' if Biden pushes this tax hike through: Trump economic adviser
Taxing unrealized capital gains could negatively hurt markets, explains one of former President Donald Trump's economic advisers Stephen Moore.
Yahoo Finance•
Is President Biden too old? How his age stacks up against the 7 oldest CEOs on the Fortune 500
The age of chief executives on this list ranges from their late 70s to early 90s.
Fortune•
Prediction: This Will Be the Best-Performing Sector of the Second Half of 2024
One sector has been a major market laggard recently, but it could be set to turn around.
Motley Fool•
SunPower Plunges After Halting Solar Installs and Shipments
(Bloomberg) -- SunPower Corp. plunged to an all-time low after the solar company told dealers it would no longer support new installations and was halting shipments. Most Read from BloombergLSE Joins Banks, Airlines in Cascade of Global DisruptionsCanada’s Immigration Minister Has a Message for Foreign Students: You Can’t All StayBrookfield Lines Up a 36-Year-Old Rising Star as Next Billionaire CEOBiden Faces Mounting Speculation, Pressure to Drop BidWall Street’s ‘Great Rotation Trade’ Takes a
Bloomberg•

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Eli Lilly to acquire Morphic in $3.2B deal

Recommended Stories

Heard on the Street: CrowdStrike May Get More Than a Slap

Blame One Stock For Most Of Magnificent 7's $1.3 Trillion Loss

‘Greatest Bubble’ Nearing Its Peak, Says Black Swan Manager

75% of Warren Buffett's $416 Billion Portfolio Is Invested in 5 Unstoppable Stocks

Investors can expect a huge reveal on Nvidia's upcoming earnings call that could silence AI critics, Goldman Sachs says

This Billionaire Founder Sold Over $13 Billion of His Company's Stock This Year Alone. Should Investors Be Worried?

Investors should 'run' if Biden pushes this tax hike through: Trump economic adviser

Is President Biden too old? How his age stacks up against the 7 oldest CEOs on the Fortune 500

Prediction: This Will Be the Best-Performing Sector of the Second Half of 2024

SunPower Plunges After Halting Solar Installs and Shipments